Factors affecting CRISPR-Cas defense against antibiotic resistance plasmids harboured by Enterococcus faecalis laboratory model strains and clinical isolates.

IF 3.5 4区 生物学 Q3 MICROBIOLOGY
Tahira Amdid Ratna, Belle Marco Sharon, Cesar Alejandro Barros Velin, Kelli Palmer
{"title":"Factors affecting CRISPR-Cas defense against antibiotic resistance plasmids harboured by <i>Enterococcus faecalis</i> laboratory model strains and clinical isolates.","authors":"Tahira Amdid Ratna, Belle Marco Sharon, Cesar Alejandro Barros Velin, Kelli Palmer","doi":"10.1099/mic.0.001601","DOIUrl":null,"url":null,"abstract":"<p><p><i>Enterococcus faecalis</i> is a Gram-positive bacterium and opportunistic pathogen that acquires resistance to a wide range of antibiotics by horizontal gene transfer (HGT). The rapid increase of multidrug-resistant (MDR) bacteria including MDR <i>E. faecalis</i> necessitates the development of alternative therapies and a deeper understanding of the factors that impact HGT. CRISPR-Cas systems provide sequence-specific defense against HGT. From previous studies, we know that <i>E. faecalis</i> CRISPR-Cas provides sequence-specific anti-plasmid defense during agar plate biofilm mating and in the murine intestine. Those studies were mainly conducted using laboratory model strains with a single, CRISPR-targeted plasmid in the donor. MDR <i>E. faecalis</i> typically possess multiple plasmids that are diverse in sequence and may interact with each other to impact plasmid transfer and CRISPR-Cas efficacy. Here, we altered multiple parameters of our standard <i>in vitro</i> conjugation assays to assess CRISPR-Cas efficacy, including the number and genotype of plasmids in the donor, and laboratory model strains as donor versus recent human isolates as donor during conjugation. We found that the plasmids pTEF2 and pCF10, which are not targeted by CRISPR-Cas in our recipient, enhance the conjugative transfer of the CRISPR-targeted plasmid pTEF1 into both WT and CRISPR-Cas-deficient (via deletion of <i>cas9</i>) recipient cells. However, the effect of pTEF2 on pTEF1 transfer is much more pronounced, with a striking 6-log increase in pTEF1 conjugation frequency when pTEF2 is also present in the donor and recipients are deficient for CRISPR-Cas (compared with 4-log for pCF10). Overall, this study provides insight about the interplay between plasmids and CRISPR-Cas defence, opening avenues for developing novel therapeutic strategies to curb HGT among bacterial pathogens and highlighting pTEF2 as a plasmid for additional mechanistic study.</p>","PeriodicalId":49819,"journal":{"name":"Microbiology-Sgm","volume":"171 9","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476151/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbiology-Sgm","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1099/mic.0.001601","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Enterococcus faecalis is a Gram-positive bacterium and opportunistic pathogen that acquires resistance to a wide range of antibiotics by horizontal gene transfer (HGT). The rapid increase of multidrug-resistant (MDR) bacteria including MDR E. faecalis necessitates the development of alternative therapies and a deeper understanding of the factors that impact HGT. CRISPR-Cas systems provide sequence-specific defense against HGT. From previous studies, we know that E. faecalis CRISPR-Cas provides sequence-specific anti-plasmid defense during agar plate biofilm mating and in the murine intestine. Those studies were mainly conducted using laboratory model strains with a single, CRISPR-targeted plasmid in the donor. MDR E. faecalis typically possess multiple plasmids that are diverse in sequence and may interact with each other to impact plasmid transfer and CRISPR-Cas efficacy. Here, we altered multiple parameters of our standard in vitro conjugation assays to assess CRISPR-Cas efficacy, including the number and genotype of plasmids in the donor, and laboratory model strains as donor versus recent human isolates as donor during conjugation. We found that the plasmids pTEF2 and pCF10, which are not targeted by CRISPR-Cas in our recipient, enhance the conjugative transfer of the CRISPR-targeted plasmid pTEF1 into both WT and CRISPR-Cas-deficient (via deletion of cas9) recipient cells. However, the effect of pTEF2 on pTEF1 transfer is much more pronounced, with a striking 6-log increase in pTEF1 conjugation frequency when pTEF2 is also present in the donor and recipients are deficient for CRISPR-Cas (compared with 4-log for pCF10). Overall, this study provides insight about the interplay between plasmids and CRISPR-Cas defence, opening avenues for developing novel therapeutic strategies to curb HGT among bacterial pathogens and highlighting pTEF2 as a plasmid for additional mechanistic study.

影响CRISPR-Cas防御粪肠球菌实验室模型菌株和临床分离株携带的抗生素耐药质粒的因素
粪肠球菌是一种革兰氏阳性细菌和条件致病菌,通过水平基因转移(HGT)获得对多种抗生素的耐药性。包括耐多药大肠杆菌在内的耐多药(MDR)细菌的迅速增加,需要开发替代疗法并更深入地了解影响HGT的因素。CRISPR-Cas系统提供针对HGT的序列特异性防御。从之前的研究中,我们知道E. faecalis CRISPR-Cas在琼脂板生物膜交配和小鼠肠道中提供序列特异性抗质粒防御。这些研究主要是使用实验室模型菌株进行的,在供体中有一个单一的crispr靶向质粒。耐多药粪大肠杆菌通常具有多个质粒,这些质粒序列不同,并且可能相互作用以影响质粒转移和CRISPR-Cas的效果。在这里,我们改变了标准体外偶联试验的多个参数来评估CRISPR-Cas的有效性,包括供体中质粒的数量和基因型,以及在偶联过程中作为供体的实验室模型菌株与作为供体的近期人类分离株的对比。我们发现,在我们的受体中,未被CRISPR-Cas靶向的质粒pTEF2和pCF10增强了CRISPR-Cas靶向质粒pTEF1在WT和CRISPR-Cas缺陷(通过缺失cas9)受体细胞中的共轭转移。然而,pTEF2对pTEF1转移的影响要明显得多,当pTEF2也存在于供体中,而受体缺乏CRISPR-Cas时,pTEF1偶联频率增加了惊人的6对数(与pCF10的4对数相比)。总的来说,本研究提供了质粒与CRISPR-Cas防御之间相互作用的见解,为开发新的治疗策略来抑制细菌病原体中的HGT开辟了道路,并突出了pTEF2作为质粒的额外机制研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Microbiology-Sgm
Microbiology-Sgm 生物-微生物学
CiteScore
4.60
自引率
7.10%
发文量
132
审稿时长
3.0 months
期刊介绍: We publish high-quality original research on bacteria, fungi, protists, archaea, algae, parasites and other microscopic life forms. Topics include but are not limited to: Antimicrobials and antimicrobial resistance Bacteriology and parasitology Biochemistry and biophysics Biofilms and biological systems Biotechnology and bioremediation Cell biology and signalling Chemical biology Cross-disciplinary work Ecology and environmental microbiology Food microbiology Genetics Host–microbe interactions Microbial methods and techniques Microscopy and imaging Omics, including genomics, proteomics and metabolomics Physiology and metabolism Systems biology and synthetic biology The microbiome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信